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Abstract
Background: It is well documented that mothers of children with intellectual disabilities or autism experience
elevated stress, with mental health compromised. However, comparatively little is known about mothers of children
with rare genetic syndromes. This study describes mental health and well-being in mothers of children with 13 rare
genetic syndromes and contrasts the results with mothers of children with autism.
Methods: Mothers of children with 13 genetic syndromes (n = 646; Angelman, Cornelia de Lange, Down, Fragile-X,
Phelan McDermid, Prader-Willi, Rett, Rubenstein Taybi, Smith Magenis, Soto, Tuberous Sclerosis Complex, 1p36
deletion and 8p23 deletion syndromes) and mothers of children with autism (n = 66) completed measures of
positive mental health, stress and depression. Using Bayesian methodology, the influence of syndrome, child ability,
and mother and child age were explored in relation to each outcome. Bayesian Model Averaging was used to
explore maternal depression, positive gain and positive affect, and maternal stress was tested using an ordinal
probit regression model.
Results: Different child and mother factors influenced different aspects of mental well-being, and critically, the
importance of these factors differed between syndromes. Maternal depression was influenced by child ability in
only four syndromes, with the other syndromes reporting elevated or lower levels of maternal depression
regardless of child factors. Maternal stress showed a more complex pattern of interaction with child ability, and for
some groups, child age. Within positive mental health, mother and child age were more influential than child
ability. Some syndromes reported comparable levels of depression (SMS, 1p36, CdLS) and stress (SMS, AS) to
mothers of children with autism.
Conclusions: Bayesian methodology was used in a novel manner to explore factors that explain variability in
mental health amongst mothers of children with rare genetic disorders. Significant proportions of mothers of
children with specific genetic syndromes experienced levels of depression and stress similar to those reported by
mothers of children with autism. Identifying such high-risk mothers allows for potential early intervention and the
implementation of support structures.
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Background
Mothers of children with neurodevelopmental disorders
and/or intellectual and developmental disabilities (IDD)
report elevated levels of stress and affective symptoms
when compared to mothers of typically developing
children [1–3]. These differences in maternal well-being
are established by the time children are 3–5 years of age
[3, 4] and continue over time [5].
Given these elevated levels of stress and affective
symptoms, an important question is whether there are
particularly high-risk groups of mothers that might be
targeted for early support and hence whether the nature
of a child’s neurodevelopmental disability is associated
with compromised mental health. To date, the focus has
been on mothers of children with autism, with consist-
ent reports of higher levels of mental health difficulties
and stress when compared to mothers of children with
other neurodevelopmental disorders, including general
IDD [3, 4, 6]. A meta-analysis of such studies confirms
that whilst mothers of children with autism are more
impacted by parenting stress, the extent to which they
differ from other mothers varies considerably depending
upon the comparison groups [7]. The majority of re-
search has focused upon mothers as they tend to be the
primary caregivers. The limited studies that have in-
cluded or focused upon fathers draw mixed conclusions
with regards to levels of stress compared to mothers and
compared to fathers of typically developing children [8].
In contrast to the extensive literature focusing upon
the mental health of mothers of children with autism,
research into the mental health of mothers of children
with known genetic aetiologies associated with neurode-
velopmental disorders is comparatively sparse. Although
each genetic syndrome affects only a small proportion of
people, collectively the prevalence is relatively high [9].
Given that a molecular diagnosis can now be identified
for most individuals with severe IDD and that the num-
ber of syndromes associated with IDD is increasing with
increased genetic techniques (see [10] for a review), fur-
ther research is needed to understand the pattern of
aetiological group differences and factors that may be
contributing to this.
Studies investigating maternal mental health in syn-
dromes have focused predominantly on the most com-
mon genetic causes of IDD such as Fragile-X syndrome
(FXS) and Down syndrome (DS), with relatively consist-
ent results. It was concluded that mothers of children
with FXS displayed fewer signs of compromised psycho-
logical well-being than mothers of children with autism,
but more than mothers of children with DS [11].
Mothers of children with DS report lower levels of stress
and negative impact than mothers of children with aut-
ism [12] and, in some studies, report levels of mental
health problems comparable to those experienced by
parents of typically developing children [13]. This raises
the possibility that the so-called “Down syndrome ad-
vantage” [14] might drive the results of the few studies
reporting parental stress in rarer genetic syndromes, as
they typically use DS as a contrast group. The findings
that parents of children with Williams or Smith-Magenis
syndromes report more family problems and pessimism
about their child’s future than parents of children with
DS [15], and that parents of children with Cornelia de
Lange syndrome (CdLS) report higher levels of stress
than parents of children with DS [16], must therefore be
interpreted in relation to the use of DS as a contrast
group. An alternative approach to comparing to DS by
comparing levels of parental mental health in three rare
genetic syndromes (CdLS, Cri du Chat, and Angelman
syndromes [AS]) with parents of children with autism
has been suggested [17], citing them as a useful bench-
mark high-stress comparison group. This strategy is
adopted in this study.
The model of “direct” and “indirect” effects of specific
syndromes and behaviour [18] can be used to hypothe-
sise why syndrome-associated differences in maternal
mental health may result. A genetic syndrome may pre-
dispose an individual to display certain behaviours or
patterns of behaviour; described as the “direct” effect of
the syndrome. These behaviours may evoke particular
reactions from others, which is described as the “indir-
ect” effect of the syndrome (discussed further in [19]).
Syndrome characteristics may influence child presenta-
tion (the “direct” effect) which will then have differing
impact upon parenting behaviours and consequences for
parental well-being (the “indirect effect”). The available
research in DS and FXS supports the possibility that
syndromes potentially have an indirect effect on parents.
However, the comparative risk for maternal mental
health problems in syndromes other than these is diffi-
cult to comprehend because studies have tended to use
different measures and designs and compare only one or
two syndrome groups. Consequently, this limits the ex-
tent to which the available studies on the rarer syn-
dromes can be compared with each other.
The main aim of the present study is to address the
methodological limitations of existing research into the
mental health of parents of children with genetic syn-
dromes associated with neurodevelopmental disorders
or disabilities. To do so, we recruited families of children
with 13 different genetic syndromes and used the same
measures with each group. In order to benchmark the
levels of maternal well-being in these 13 syndromes and
address the question of whether any of the syndrome
groups in this study represent an especially high-risk
group, the results were compared with those of a group
of mothers of children with autism. Autism was chosen
as the high-risk comparison group as multiple
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population-based studies as well as systematic reviews
and meta-analyses [3, 7, 20–23] have identified parents
of children with autism as being at higher risk of mental
health difficulties than parents of children without aut-
ism, children with rare genetic syndromes, children with
other disabilities and typically developing children. Effect
sizes for this increased risk are consistently large, for ex-
ample, [7]‘s meta-analysis of studies focusing upon par-
ent stress in parents of children with autism report an
effect size of 1.54 for comparisons of parents of children
with autism to parents of typically developing children
and 0.64 for comparisons to parents of children with
other disabilities. The combination of the high volume
of research from across the world with the consistent
finding of elevated levels of maternal mental health diffi-
culties provides a strong rationale for using autism as a
“high-risk” comparison group against which the other
syndromes can be compared.
In addition to a focus on mental health problems, we
are mindful of the growing research base regarding the
positive impact of caring for an individual with IDD
[24, 25]. Intriguingly, a population-based study [3]
found no disability group differences and no evidence
of differences compared to mothers of children without
disabilities for maternal positive mental health. A simi-
lar pattern of no group differences for positive impact
has been found in genetic syndrome family research
studies [12, 26], but the research remains limited.
Therefore, we included both negative and positive
well-being measures in the present research to answer
the following research questions:
1. What are the profiles of positive mental health,
stress and depression in mothers of children with a
range of rare genetic syndromes and how do these
compare with mothers of children with autism?
2. Does genetic syndrome predict levels of maternal
mental health and if so, is this more predictive than
basic child variables that differ between the
syndromes, such as level of ability?
Methods
Participants
For all of the syndrome groups included in the study
with the exception of Rett syndrome (RTT) (AS, CdLS,
DS, FXS, Phelan-McDermid [PMS], Prader-Willi [PWS],
Rubinstein-Taybi [RTS], Soto, Smith-Magenis [SMS],
Tuberous Sclerosis Complex [TSC], 1p36 deletion syn-
drome, 8p23 deletion syndrome and the autism group
[ASD]), questionnaire packs were distributed to mem-
bers of each syndrome support group within the UK.
[27] provides detailed information on the recruitment
process but briefly, questionnaire packs were provided
to the syndrome support groups who then sent them
out to their members. The research team only received
information on demographics, child and family variables
from the participants who consented and returned their
questionnaire. The 87 mothers of daughters with RTT
were recruited in a study which used the British Isles
Rett Syndrome Survey (BIRSS) as a sampling frame (see
[28] for further details).
Caregivers from 816 families responded and consented
to take part. Due to small numbers and the lack of abil-
ity to examine differences across groups, thirty-nine
(3.3%) were excluded because they were not the child’s
mother or adoptive mother (i.e. were fathers, grandpar-
ents, foster carers or paid carers) and 11 (1.2%) were ex-
cluded as the child was aged under 2 years. Respondents
who completed fewer than 75% of items in the question-
naires of interest to this study were excluded to minim-
ise the impact of missing data. As per [27], data were
excluded if the participant did not have a genetic diag-
nosis from a clinical geneticist, pediatrician, neurologist
or psychiatrist. In relation to the ASD group, partici-
pants who had scores below the cut-off of 15 on the So-
cial Communication Questionnaire (SCQ) [29] were
excluded to provide additional confidence in the re-
ported diagnoses. To reduce the risk of potential overlap
between the ASD and the syndrome groups, participants
in the autism group were asked if their child had any
additional diagnoses or a diagnosis of a genetic syn-
drome. No participants listed any genetic syndrome in
addition to the autism diagnosis.
Following exclusions, a sample of 712 mothers was
retained for analysis. The sample consisted of 646
mothers of children with one of 13 genetic syndromes
and 66 mothers of children with ASD. Table 1 summa-
rises the number, age and gender distribution of the chil-
dren and age of the mothers. The range in sample sizes
partly reflects the range in prevalence rates for the
syndromes. For example, the prevalence of AS
(1:10,000-40,000) [30] is considerably lower than that for
FXS (1:5,000) [31]. The current article does not allow for
a description of the genetic cause or phenotype of each
individual syndrome but excellent descriptions are avail-
able in Table 1 of [32] and within the wider literature.
Demographic characteristics
The mean age of the 712 children was 15.2 years (sd 9.5)
and the mean age of the mothers was 46.6 years (sd 9.8).
Fifty-seven percent of the children were male and 96.9%
were the participants’ natural mothers, with the remain-
der being long-term adoptive mothers. Gender differ-
ences were as expected given that only males with FXS
were recruited; RTT almost exclusively affects females,
and ASD spectrum disorder is more prevalent in males.
However, a higher proportion of males than expected
was also found in the 1p36 syndrome group. Data from
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the Wessex questionnaire (see Measures section below)
reflect the different physical and cognitive profiles asso-
ciated with the different syndromes.
Ethical considerations
Ethical approval was obtained for this study in 2010 from
Coventry Research Ethics Committee, as part of a larger
ongoing study entitled ‘Understanding behaviour and fam-
ily adjustment in individuals with neurodevelopmental
disorders’ (REC reference number: 10/H1210/01).
All procedures performed were in accordance with the
ethical standards of the institutional research commit-
tees and with the 1964 Helsinki declaration and its later
amendments or comparable ethical standards.
Informed consent was obtained from individuals who
had the capacity to provide consent themselves. For those
who did not have capacity to provide their own consent,
parents or carers were able to act as consultees. Consultees
were asked to advise on what the wishes of the individual
would be if they were able to consent from themselves.
Measures
A background questionnaire was used to collect demo-
graphic information and, for the ASD group, included
the Social Communication Questionnaire [29]. The
Wessex Scale [33] was also used to collect data on each
child’s mobility, self-help scores, speech, vision and hear-
ing. Within this study, the Wessex self-help scale was
used as a proxy measure of ability (as per [34, 35]). The
mothers then completed the following four question-
naires addressing dimensions of their well-being.
The Positive Gain Scale (PGS) [36] comprises seven
items to assess the direct positive aspects of having a
child with a disability, such as “since having this child I
feel I have grown as a person”. Each item is rated on a
5-point Likert scale. These scales were reverse coded for
this study, so the higher the score, the more positive
gains reported by the participant. Internal consistency is
good, with Cronbach’s Alpha being reported as .71 [17]
and .93 within the current sample.
To minimise demands upon mothers, the Positive
Affect Scale-5 (PAS5) was used (as per [17]). This com-
prises five items from the Positive Affect Scale (PANAS)
[37] with the highest total item correlations. Correlation
of the full 10-item Positive Affect Scale and the Positive
Affect Scale-5 as moderate to strong (r = .60) has been
reported [17]. Participants were presented with five de-
scriptive words, such as “strong” and “interested” and
asked to rate the extent to which they felt this way over
the past week on a Likert-type scale. Cronbach’s Alpha
was .86 within the current sample.
The seven items assessing depression were selected
from the Hospital Anxiety and Depression Scale (HADS)
[38]. Although this measure was published in 1983, it
continues to have good test-retest reliability and concur-
rent validity data reported at subscale and total score
levels for parents of children with neurodevelopmental
disorders [39, 40]. In the present sample, Cronbach’s
Alpha was strong (.89).
The Parent and Family Problems Subscale from the
Questionnaire on Resources and Stress – Short Form
(QRSF) [41], was used to measure general stress asso-
ciated with raising a child with intellectual disabilities.
The five items assessing depression were excluded to
reduce potential overlap (as per [17]). This measure
continues to be used and reported in recent studies
of children with a range of disabilities (e.g. [42, 43]).
Mothers were asked to circle “true” or “false” on seven
items, such as “other members of the family have to do
without things because of <name>”. The Kuder-Richardson
coefficient for this version of the questionnaire was .82
within the current sample.
Table 1 Demographic characteristics (age, gender) and descriptive data by syndrome group
AS ASD CdLS DS FXSa PMS PWS RTTa RTS SMS Soto TSC 1p36 8p23 Total
n 28 66 44 29 102 31 101 87 47 20 38 71 26 22 712
Child mean
age (sd, range)
10.9
3.3
(3–15)
15.5
6.5
(6–42)
12.8
8.2
(2–45)
25.4
11.8
(8–45)
15.0
8.2
(2–42)
11.3
8.4
(2–37)
12.2
8.1
(2–45)
20.1
10.2
(4–47)
21.3
10.5
(6–53)
11.6
7.2
(3–32)
15.3
9.3
(2–43)
18.8
10.7
(2–50)
10.9
8.9
(2–39)
10.8
5.5
(4–21)
15.2
9.5
(2–53)
% Male child 46.4 86.4 47.7 53.3 100 45.2 52.3 0 55.3 60 68.4 60.6 78.6 68.2 57.0
Maternal mean
age (sd)
40.8
4.9
47.9
6.8
45.1
9.1
59.1
12.3
45.6
9.5
42.3
9.9
44.5
8.5
50.7
9.2
49.8
9.9
43.7
8.5
46.3
8.3
48.1
10.3
41.2
10.8
39.6
6.1
46.6
9.8
Speech % verbal 32.1 92.4 68.2 100 94.2 38.7 98 – 83 80 92.1 76.1 57.7 91.9 82.3
Hearing % normal 92.9 98.5 56.8 58.6 97.1 90.1 99.0 – 80.9 55 76.3 94.4 61.5 90.9 87.3
Vision % normal 85.7 86.4 63.6 43.3 88.3 71.0 73.3 – 51.1 75.0 73.7 88.7 26.9 45.5 74.4
Mobility % mobile 39.3 92.4 54.5 100 86.4 71 78.2 – 74.5 70 81.6 78.9 46.2 59.1 76.6
Self-help % able/partly able 14.3 89.2 40.9 90 88.2 22.6 78.2 – 80.9 60 84.2 66.2 42.3 59.1 70.4
aGender distribution can be explained in these groups as only males with FXS were recruited and RTT almost exclusively affects females
AS Angelman Syndrome, ASD Autism Spectrum Disorder, CdLS Cornelia de Lange syndrome, DS Down Syndrome, FXS Fragile-X Syndrome,
PMS Phelan McDermid Syndrome, PWS Prader-Willi syndrome, RTT Rett Syndrome, RTS Rubenstein Taybi syndrome, SMS Smith Magenis Syndrome,
TSC Tuberous Sclerosis Complex, 1p36 1p36 deletion syndrome, 8p23 8p23 deletion syndrome
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Statistical analysis
Bayesian methods are emerging in developmental re-
search, and in psychological research more broadly [44].
The approach has been described and discussed in articles
in a range of journals relevant to the field of intellectual
disability research (e.g. [44–46]). In brief, Bayes’s theorem
is a model for learning from data, and consequently, the
Bayesian paradigm interprets probability as the subjective
experience of uncertainty [47]. As noted [46], Bayesian
methods are not meant to test whether a null hypothesis
should be rejected, but aim to capture the strength of the
evidence for specific hypothesised beliefs. Instead of as-
suming that there is a fixed but unknown parameter of
interest (e.g. one true mean, one true regression coeffi-
cient), the Bayesian view is that all unknown parameters
should be treated as uncertain, and therefore should be
described by a probability distribution [44].
Bayesian analysis formulates this probability distribution
for the parameters (and functions of the parameters) using
a combination of data (a likelihood distribution) and a prior
distribution, which represents the researchers’ knowledge
prior to data collection. Although there is a wealth of litera-
ture documenting elevated stress and depression in
mothers of children with ASD, there is comparatively little
on mothers of children with genetic syndromes, particularly
relating to positive mental health. Given this, it was decided
that there was insufficient information across all the syn-
dromes in this study to set an informative prior belief for
how each syndrome may differ, so the hypothesised belief
was that there is no difference on measures of mental
health between the syndrome groups and ASD. The prior
distribution for parameters for syndromes other than ASD
was set as a normal distribution centered around zero, and
the variance was set to allow variation from ASD. The ASD
group was used as the base-level parameter, and a compari-
son and marker for elevated difficulties was modelled.
The data analysis was undertaken in three stages for
each measure of maternal mental health except stress,
where only the first two stages were undertaken due to
the data being measured on a dichotomous scale (for
which Bayesian model averages have not yet been devel-
oped). The continuous measure scale data were first
analysed as a linear regression where only syndrome was
considered, using a Bayesian framework. The linear re-
gression model used in stage 1 is represented by:
Measure  N Xβ; σ2 
Xβ ¼ βAutism þ βsyndrome difference autism
p βAustism
   N ηA; ε2A
 
p βSyndrome difference autism
 
 N ηB; ε2B
 
p σ2
   InvGamma v;ωð Þ
In this framework, the likelihood of the measure of
interest (depression, positive gain and positive affect) is
considered to be normally distributed, with a mean
based on the regression model parameters, the explana-
tory data and constant variance. The unknown regres-
sion parameters (β) have a prior distribution that is also
normal, with hyperparameters for the mean and variance
given in Table 2. The error variance, σ2 is modelled
using an inverse gamma prior distribution.
Computation was performed using Markov Chain
Monte Carlo (MCMC) estimation with the MCMCregress
function from the MCMCpack library [48] in R [49]. The
results were then presented graphically and grouped using
the estimated posterior distributions that were statistically
similar. Within each figure, shadings were used to repre-
sent groupings with similar posterior estimates and cred-
ible intervals of 80%, 50% and 20% provided.
As a Bayesian regression model determined that
Wessex score, child and maternal age varied between
groups, these factors were entered into a classification
and regression tree (CART) to explore their impact, if
any, on the measure of maternal well-being. This CART
analysis informed the final stage of the analysis by
highlighting potential interactions and allowing us to es-
timate suitable factorisation levels, such as carer age, on
continuous data. Continuous data are unlikely to change
gradually as a regression model would imply, but are
more likely to cluster into a category. A Bayesian model
averaging (BMA) approach was used to assess the rela-
tive influence of each of these factors on maternal men-
tal health. BMA is an extension of the Bayesian
inference methods that consider both model and param-
eter uncertainty. Instead of selecting one particular
model as “true”, BMA combines weighted fitted values
from multiple models to estimate the posterior distribu-
tion of the model parameters. Using this technique, a
posterior mean (the value expected under the BMA),
posterior standard deviation and the probability of a var-
iable’s inclusion are provided. The probability of inclu-
sion reflects how certain the model is that the
coefficient is not zero, taking into account model uncer-
tainty and the other variables. An inclusion probability
of 1 indicates 100% certainty that the factor should be
included in the model, and an inclusion probability of .5
Table 2 Fixed hyperparameters for the prior distributions of linear
regression coefficients βASD and βSyndrome_difference_ASD and the
variance (σ2) for the continuous measures of maternal mental health
Depression Positive Gain Positive Affect
ηA 7.6 21.0 15.0
εA 0.5 2.0 0.5
ηB 0.0 0.0 0.0
εB 2.0 2.0 2.0
ν 0.001 0.001 0.001
ω 0.001 0.001 0.001
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indicates 50% certainty [50]. BMA computation was esti-
mated using the R BAS library [51] with the default
prior distributions for all parameters.
Maternal stress was measured on a scale derived from
dichotomous variables, so an ordinal probit regression
model was fitted using an MCMC scheme. Vague priors
were employed to model the transition of individuals
from one stage of stress to another in an ordered se-
quence. Estimation was conducted using the MCMCo-
probit function from the MCMCpack library [48] in R
[52], using the algorithm proposed by [53].
Results
The simulated posterior distributions with credible inter-
vals for each of the four measures are displayed in the
upper panels of Figs. 1, 2, 3, 4. Data are presented in as-
cending order across the groups, meaning that the order
of syndrome groups differs between each figure. Higher
scores represent higher levels of the area being assessed,
that is, higher levels of positive affect and positive gain,
but also higher levels of depression and stress. Group-
ings (represented by shadings) are based on the posterior
probabilities documented in Table 3. The CART dia-
grams are provided in the Additional file 1, items 1 to 4.
Positive mental health
Positive gain
The upper panel of Fig. 1 documents the simulated pos-
terior distributions for positive gain with credible inter-
vals across all syndrome groups and ASD. The CART
informed the inclusion of syndrome group, child age
(≤/> 8) and maternal age (≤/> 53) in the BMA. The re-
sults of the BMA (summarised graphically in the lower
panel of Fig. 1) indicate two groups based upon
syndrome (inclusion probability .75), with Group 1
(containing ASD, AS, CdLS, FXS, PWS, SMS, Soto,
1p36, 8p23 and TSC) reporting significantly lower posi-
tive gain than Group 2 (containing DS, RTS, PMS,
RTT). Increasing child age (inclusion probability .41)
and carer age (inclusion probability .36) had a mild
negative influence on positive gain, with a slightly stron-
ger impact of carer age in syndrome Group 2 than in
Group 1 (inclusion probability .41).
Positive affect
The upper panel of Fig. 2 documents the simulated pos-
terior distributions for positive affect with credible inter-
vals across all syndrome groups and ASD. The CART
informed the inclusion of syndrome group and maternal
age (</ ≥36) into the BMA. The results of the BMA
(summarised graphically in the lower panel of Fig. 2) in-
dicate two groups based upon syndrome (inclusion
probability .70), with Group 1 (containing ASD, CdLS,
DS, FXS, PMS, PWS, RTS, SMS, Soto, 1p36, TSC)
reporting significantly lower positive affect than Group 2
(containing AS, RTT, 8p23). Increasing carer age (inclu-
sion probability .89) had a strong negative influence on
positive affect, with a slightly stronger impact of carer
age in syndrome Group 1 than in Group 2 (inclusion
probability .37).
Mental health difficulties
Depression
The upper panel of Fig. 3 documents the simulated pos-
terior distributions for depression with credible intervals
across all syndrome groups and ASD. The CART in-
formed the inclusion of syndrome group and Wessex
Score (=/< 9) into the BMA. The results of the BMA
(summarised graphically in the lower panel of Fig. 3) in-
dicate three groups based upon syndrome (inclusion
probability .84 for Group 2, 1.0 for Group 3), with
Group 1 (containing ASD, CdLS, SMS, 1p36) reporting
significantly higher depression than Group 2 (containing
AS, FXS, PWS, TSC, PMS), both of which report higher
depression than Group 3 (containing DS, Soto, RTS,
RTT, 8p23). Whether the child’s Wessex self-help score
was at or below the maximum did not influence depres-
sion scores in Group 1 or Group 3, but had a significant
influence on Group 2 (inclusion probability .77), with
higher levels of depression in mothers of children who
had a Wessex score below the maximum score of 9. It is
important to note that depression scores in Group 1 are
much higher than those for Groups 2 and 3, and as such,
the Wessex score has limited ability to increase the de-
pression rating.
As the HADS has a cut-off score for clinical levels of
depression, the inclusion probability for mothers in each
syndrome group being depressed was calculated and is
presented in Table 3 (without consideration of child or
carer variables). The syndromes in Group 1 of the BMA
(ASD, CdLS, SMS, 1p36) have a 49–56% risk of scoring
above the clinical cut-off, those in Group 2 (AS, FXS,
PWS, TSC, PMS) a 37–41% risk, and those in Group 3
(DS, Soto, RTS, RTT, 8p23) a 29–35% risk.
Maternal stress
The upper panel of Fig. 4 documents the simulated pos-
terior distributions for maternal stress with credible in-
tervals across all syndrome groups and ASD. The CART
identified syndrome group first, then Wessex (=/< 9) and
finally child age (≤/> 8) as factors influencing maternal
stress scores. The lower panel of Fig. 4 depicts simulated
posterior mean scores for each syndrome only for those
scoring below the maximum score of 9 on the Wessex
self-help score. The data are divided by age group, with
the grey line representing maternal stress levels for each
syndrome when the child is age 8, and the black line
representing each syndrome when the child is age 16.
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These variables were entered into the ordinal probit re-
gression. Maternal stress tended to increase with child
age (Bayesian posterior p-value = .01) with the exception
of Soto (Bayesian posterior p-value <.01), AS (posterior
p-value = .02), and SMS (Bayesian posterior p-value
= .004) where it decreased with child age.
Discussion
This is the first study exploring mental health and
well-being in mothers of children with 13 rare genetic syn-
dromes associated with neurodevelopmental disorders or
disabilities in relation to each other and to mothers of
children with ASD. It also provides the first published de-
scription of which we are aware of stress, depression and
positive mental health of mothers of children with four
syndromes: RTS, Soto, 1p36 and 8p23. The use of the
Bayesian approach is both novel and important, as it al-
lows for exploration of relative influences on different
child or mother factors in relation to a range of maternal
mental health measures whilst modelling for the uncer-
tainty in this underresearched area.
The first key finding is that for different aspects of
mental health, including positive mental health, different
child and mother factors influenced the groupings of
scores, and that the importance of these factors on ma-
ternal mental health is different for different syndromes.
For example, the BMA for depression notes that
mothers of children with some syndromes (ASD, CdLS,
SMS, 1p36) had elevated levels of depression regardless
of child ability or age, or age of the mother, and others
had relatively low levels of depression (DS, Soto, RTS,
RTT, 8p23) regardless of these variables. However, levels
of maternal depression in AS, FXS, PWS, TSC and PMS
showed a syndrome by ability interaction: mothers of
children with the highest ability score on the Wessex
had lower depression scores than mothers of children
who had a score below the maximum on the Wessex
(posterior mean depression ratings 4.46 and 6.26
respectively).
For maternal stress, the relationship was more com-
plex, with the CART decision tree and regression both
highlighting an interaction between Wessex score and
syndrome, but also identifying the importance of child
age within those with lower than maximum on the
Wessex within a specific group of syndromes. For that
group, stress tended to increase with child age: however,
Fig. 1 Positive Gain by syndrome group (upper panel) and by BMA groupings (lower panel). Upper panel: Estimated posterior mean of Positive
Gain by syndrome group. Extended lines represent Credible Intervals: solid 20%, dashed 50%, dotted 80%. Vertical dashed line is mean of all
participants. Lower panel: Posterior probabilities of Positive Gain based on BMA. Group 1: Autism, AS, CdLS, FXS, PWS, SMS, Soto, 1p36, 8p23, TSC.
Group 2: DS, RTS, PMS, RTT
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in AS, Soto and SMS, the opposite pattern was noted.
Within positive mental health, carer and child age are
important considerations, although the BMA again
highlighted that these factors have different influences
on different groups of syndromes for different aspects of
positive mental health.
The second key finding is the identification of some
syndromes where a notable proportion of mothers will
be experiencing comparable levels of depression (SMS,
1p36, CdLS) and stress (SMS, AS) to mothers of chil-
dren with ASD, a group that has always been highlighted
within the literature as being at elevated risk for mental
health difficulties. The prevalence rates of ASD in these
syndromes vary (AS 34%, CdLS 43%, SMS 54% meet
cutoff on the SCQ, 1p36 “few cases” [54–56]), and are
comparable with some of the syndromes explored within
this paper where mothers do not report comparable
levels of mental health difficulties, for example, PMS
52.5–55%, Soto 83.3%, and RTT 61% [56–58]. Therefore,
the similarities in mental health difficulties between
these syndromes and ASD cannot be explained simply
by the presence of “autism-symptoms” within these syn-
dromes. This may suggest that different “direct effects”
of a syndrome may have differing “indirect effects” in
the context of the broader physical and cognitive pheno-
type. The finding that parents of different syndromes
have elevated scores in different aspects of mental health
difficulties is also of significance.
It is important to consider why maternal psychological
well-being may be associated with child disability aetiology
and why specific aetiologies interact differently with child
and parent characteristics for certain aspects of maternal
mental health. The research pertaining to parental stress
in idiopathic intellectual disability and ASD has
highlighted the impact of behavioural characteristics and
behaviours that challenge on parental stress in both
cross-sectional and longitudinal studies [59]. The presence
of behaviours that challenge may be a significant factor
contributing to the results reported in this study. How-
ever, the impact of behaviours that challenge on parent
stress and well-being, over and above the syndrome, dif-
fers between different syndromes (e.g. [12]). It cannot
Fig. 2 Positive Affect by syndrome group (upper panel) and by BMA groupings (lower panel). Upper panel: Estimated posterior mean scores for
Positive Affect by syndrome group. Extended lines represent Credible Intervals: solid 20%, dashed 50%, dotted 80%. Vertical dashed line is mean
of all participants. Lower panel: Posterior probabilities of Positive Affect based on BMA. Group 1: ASD, CdLS, DS, FXS, PMS, PWS, RTS, SMS, Soto,
1p36, TSC. Group 2: AS, RTT, 8p23
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therefore be assumed that the between-syndrome similar-
ities and differences in parental mental health and
well-being identified within this study can be solely ex-
plained by behavioural difficulties as “behaviour is but one
aspect of aetiology-related characteristics that affect these
children’s everyday lives” [60].
In their review of the literature, [60] highlight the im-
portance of considering the “non-behavioural” aspects
that may impact upon parental well-being including the
child’s health status, the level of caregiving required, both
parent and child personality, child facial characteristics
and physical phenotype, and the timing and
predictability-expectedness of problems. Parents of chil-
dren with different syndromes have different concerns
about their children [61] and there may be different levels
of parental acceptance and understanding of the genetic
cause (including aspects relating to hereditability) and so-
cietal acceptance of the genetic syndrome [11]. In qualita-
tive interviews, mothers of young people with genetic
syndromes reported that negative public reactions, diffi-
culties with social inclusion, problems accessing social and
medical services and a lack of accessible knowledge about
the syndrome, were factors that increased maternal stress
[62]. It is therefore critical that future explorations of ma-
ternal well-being in mothers of children with rare genetic
syndromes consider the behaviour (or behavioural pheno-
type) within the broader subset of phenotypes of the syn-
drome, including the physical (including physical
presentation and physical health) and cognitive pheno-
types (including autism symptomatology). Now that the
current study has documented that child and mother vari-
ables influence the profile of maternal mental health
across a range of genetic syndromes, researchers can begin
to model and explore further sources of variance, with a
focus on child behaviour in the context of other child, par-
ent and family characteristics. Just as [63, 64] developed
syndrome-specific models of syndromes to behaviour,
these results of further explorations could model the “in-
direct” effect of syndromes [19] to consider individual and
systemic factors within individual or groups of syndromes.
Although this is highlighted as an important avenue for
future research, it is likely that such relationships will be
complex and there will inevitably be variations both
within and between syndromes.
Parents, syndrome support groups and professionals
encourage the use of knowledge relating to genetic
Fig. 3 Depression by syndrome group (upper panel) and by BMA groupings (lower panel). Upper panel: Estimated posterior mean scores for
Depression by syndrome group. Extended lines represent Credible Intervals: solid 20%, dashed 50%, dotted 80%. Vertical dashed line is mean of
all participants.Lower panel: Posterior probabilities of Positive Gain based on BMA. Group 1: ASD, CdLS, SMS, 1p36, Group 2: AS, FXS, PWS, TSC,
PMS, Group 3: DS, Soto, RTS, RTT, 8p23
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syndromes to tailor services and provide proactive ser-
vices within syndrome-specific at-risk areas [32, 65].
The results of this study highlight potential factors in
being able to begin to identify mothers of children with
specific syndromes who may be particularly vulnerable
to mental health problems, and raise the possibility of
targeted and early support for families. Given that par-
ental stress is associated with child progress and re-
sponse to intervention [66], it is important for both
clinicians and researchers within this field to be aware
of parents who may be at increased risk of stress or
mental health problems, and who as a result, may find
it difficult to benefit from standard parenting interven-
tions. As noted [67], the best approach may be to inte-
grate stress or depression reduction techniques into the
early stages of parent training packages for high-risk
parents to maximise the effectiveness of the standard
training intervention. Studies such as this may also as-
sist with directing parents to syndrome-informed early
support and helpful resources to develop effective sup-
port networks.
Our identification of specific factors that influence
positive maternal health is novel. Positive mental health
is not the opposite of mental health difficulties, and this
is highlighted in the patterns within syndromes. For ex-
ample, although the AS mothers are amongst the most
stressed of the syndromes assessed, they are reportedly
relatively high positive affect. Interestingly, unlike the
data for stress and depression, level of ability (as mea-
sured by the Wessex) did not influence positive mental
health but instead, syndrome, child and parent age were
important. Although research on parental positivity in
the field of IDD is still in its infancy, the present re-
search suggests that there may be some within (genetic)
disability group variation that should be further explored
in relation to parent and child demographic variables.
There are several limitations to the present study.
Firstly, there is a possible ascertainment bias, as par-
ents were recruited through syndrome support groups.
The method of recruitment did not allow for any de-
tails on non-responders, who may have potentially
been experiencing more difficulties which prevented
Fig. 4 Stress by syndrome group (upper panel) and by posterior ratings (lower panel). Upper panel: Simulated posterior population scores for
Stress Ratings by syndrome group. Extended lines represent Credible Intervals: solid 20%, dashed 50%, dotted 80%. Vertical dashed line is mean
of all participants. Lower panel: Simulated posterior population stress rating of Positive Gain for children with Wessex self-help score below the
maximum, split by child age. Grey line aged 8, black line age 16. Extended lines represent percentage of expected population: solid 20%, dashed
50%, dotted 80%
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them from completing the questionnaire. There is also
no assessment of socioeconomic status. However, these
potential biases are likely to have applied across the
genetic syndrome groups, and may have had limited
impact on the cross-sectional comparison. Another
limitation is that confirmation of genetic testing was
not checked for each participant. Detailed genetic in-
formation on each participant would allow for further
exploration of maternal mental health and well-being
in relation to genetic subtypes and other factors such
as hereditability. Whilst all parents were members of
specific support groups, it was only possible to provide
some level of validation within the ASD group (by only
including participants who score above the cut-off on
the SCQ, albeit not a diagnostic criterion).
Secondly, the study is cross-sectional and has a large
sample with a large age range and so does not allow
for comment on the course or progression of the
maternal outcomes explored. The range of factors ex-
plored was also limited and as discussed above, further
studies are needed to explore the relative impact of
both behavioural and non-behavioural factors on par-
ental well-being. Longitudinal studies of parents of
children with idiopathic intellectual disability and
those with autism suggest that parental stress may re-
duce as children age, but this is largely dependent
upon help received and the presence or severity of
challenging behaviour [68]. Longitudinal methodolo-
gies would allow exploration over time of the stability
and course of the mental health of mothers of children
with rare genetic syndromes and neurodevelopmental
disorders [69] and are increasingly important given the
suggestion of change in some behavioural phenotypes
with age (e.g. [70]). Whilst it is arguably the only way
in which to collect a sample of this size and breadth,
the limitations of collecting information via informant
Table 3 Posterior estimates of mean (+ 90% credible interval) for continuous measure (median for stress) of maternal mental health
with posterior probability of differing from autism
Syndrome Positive Gain Positive Affect Depression Stress
Mean
(90% CrI)
Posterior prob.
of difference
with ASD
Mean
(90% CrI)
Inclusion prob. Mean
(90% CrI)
Posterior prob.
of difference
with ASD.
Posterior prob.
of being clinically
depressed
Median
(90% CrI)
Posterior prob.
of difference
with ASD
ASD 21.66
(20.99–22.33)
– 15.25
(14.83–15.67)
– 7.12
(6.63–7.62)
– .51 6 (6–6) –
AS 21.55
(20.20–22.89)
.56 16.60
(16.37–17.65)
.94 6.03
(4.88–7.18)
.93 .41 5 (5–6) .95
CdLS 21.66
(20.57–22.81)
.49 15.51
(15.36–16.35)
.64 6.92
(6.00–7.90)
.67 .49 5 (4–6) 1
DS 22.42
(20.91–23.86)
.80 15.93
(15.70–17.07)
.76 4.79
(3.65–5.88)
1.00 .29 3 (2–5) 1
FXS 21.66
(20.27–22.42)
.51 15.77
(15.67–16.34)
.83 5.61
(4.94–6.26)
1.00 .37 4 (4–5) 1
PMS 22.98
(21.65–24.34)
.94 16.03
(15.83–17.06)
.83 6.13
(4.99–7.30)
.90 .41 5 (4–6) 1
PWS 21.06
(20.27–21.84)
.84 15.65
(15.54–16.23)
.77 6.12
(5.47–6.79)
.97 .41 4 (4–5) 1
RTT 22.71
(21.90–23.54)
.95 17.23
(17.10–17.86)
1 4.70
(4.01–5.38)
1.00 .29 4 (3–5) 1
RTS 22.70
(21.58–23.83)
.91 15.07
(14.90–15.91)
.60 5.36
(4.43–6.29)
1.00 .34 5 (4–6) 1
SMS 21.70
(20.13–23.33)
.52 15.62
(15.35–16.79)
.64 7.66
(6.28–9.02)
.74 .56 6 (5–6) .83
Soto 21.78
(20.51–22.96)
.57 15.53
(15.32–16.49)
.63 5.42
(4.39–6.43)
.99 .35 4 (3–5) 1
TSC 21.64
(20.76–22.53)
.50 15.32
(15.17–16.01)
.54 5.88
(5.14–6.63)
.99 .39 5 (4–5) 1
1p36 21.64
(20.28–23.05)
.51 15.63
(15.42–16.68)
.66 6.96
(5.84–8.15)
.57 .50 5 (4–6) .99
8p23 21.89
(20.35–23.38)
.60 16.86
(16.64–17.96)
.96 4.82
(3.54–6.13)
1.00 .30 4 (2–5) 1
Posterior probability of difference = 1 indicates posterior distributions of estimate highly unlikely to be equivalent. Posterior probability = 0 indicates no
detectable difference
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questionnaires should be recognised, especially in rela-
tion to providing in-depth sample characterisation.
Conclusions
In conclusion, this study uses Bayesian statistical
modelling in a novel manner to highlight the level of
variability in mental health amongst mothers of chil-
dren with rare genetic disorders and neurodevelop-
mental disorders. To date, mothers of children with
autism have been shown to be a high-risk group, ex-
periencing the highest levels of stress and mental
health problems of parents with children with neuro-
developmental disorders [71]. Such a perspective
should now be broadened, as the data here show that
there are notable proportions of mothers of children
with specific genetic syndromes who experience
levels of depression and stress similar to the levels
reported by mothers of children with autism. Further
research is needed to explore the broader parent and
child characteristics, including behavioural and family
characteristics that are contributing to such elevated
mental health difficulties.
Key points
 Little is known about the mental health of mothers
of children with rare genetic syndromes
 Different aspects of maternal mental health are
influenced by different child and mother factors
 Depression levels are comparable between mothers
of children with Smith Magenis, 1p36 and Cornelia
de Lange syndromes and autism
 Stress levels are comparable between mothers of
children with Smith Magenis, Angelman syndromes
and autism
 Further work is needed to explore the relationship
between maternal mental health, syndromes and
other child and mother variables.
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